Intellectual Property Law360 provides breaking news and analysis on IP law. Coverage includes high-stakes cases involving patents, copyrights, trademarks, trade secrets, and other forms of IP, as well as policy developments and licensing deals.
A Delaware federal jury awarded Amgen Inc. $70 million in damages late Friday after finding that Hospira Inc. infringed a patent for the anemia treatment Epogen, rejecting Hospira's argument that it was protected by a safe harbor meant for companies seeking federal approval for biosimilar products.
A Federal Circuit decision Thursday setting guidelines where patent suits can be filed — and rejecting venue rules set by an Eastern District of Texas judge — provides need much-needed clarity in a contentious area of the law and should result in many cases leaving the Texas court, attorneys say.
The Federal Circuit on Friday denied Arista Networks’ request to stay a U.S. International Trade Commission ban on its products that infringe on Cisco Systems’ networking equipment patents that the Patent Trial and Appeal Board later invalidated, but said Arista’s redesigned products could enter the country.
A Patent Trial and Appeal Board panel on Friday allowed ON Semiconductor Corp. to challenge Power Integrations Inc.’s electronic power regulation patent despite having undergone a merger with Fairchild Semiconductor International Inc., finding the patent invalid as obvious.
Massachusetts' highest court recently agreed to review a ruling that shoe maker Vibram's insurance companies can't recoup the sums they paid to defend the company in a trademark dispute, and attorneys say a ruling that the insurers do have a right to reimbursement could lead policyholders to try to limit their litigation costs.